Good morning, everyone, and how are you today? We are doing just fine, thank you, courtesy of a cool breeze and a warm and shiny sun enveloping the Pharmalot campus. Our short people have departed for their destinations and our official mascot is snoozing comfortably in a corner. All of which is to say that we have a quiet moment to focus on the tasks at hand — brewing another cup of stimulation and foraging for interesting items. So time to get on with it. Here are some tidbits to help you on your own journey. Hope you have a smashing day. …

On the eve of a trial, Johnson & Johnson (JNJ) agreed to pay $9.9 million to settle a lawsuit brought by Washington state accusing it of misrepresenting the risks of pelvic mesh implants, the Associated Press writes. Attorney General Bob Ferguson sued the health-care giant in 2016, saying it failed to tell patients and doctors about the risks and occurrences of dire, sometimes irreversible complications, including urinary dysfunction, loss of sexual function, constipation, and severe pain. J&J did not admit wrongdoing. The trial had been due to start on Monday in state court.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy